RICE HALL JAMES & ASSOCIATES, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001230765

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHigh Turnover how tags are computed

Q2 2025 · 247 positions · Total reported value $1.86B · Top-10 concentration 25.5% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 77.5% · 9 new · 172 cut · 12 exited

Active Share (vs S&P 500): 98.5% · vs QQQ: 99.5% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -4.7% · vs SPY -6.9% · Prev Value $2.05B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +5.1% · vs SPY +3.0% · Latest Value $1.89B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q2 2025 13F filing, RICE HALL JAMES & ASSOCIATES, LLC disclosed 247 equity positions with a combined reported value of $1.86B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 25.5% of reported value. HoldingsHub classifies the profile as Mid / High Turnover.

The largest disclosed positions as of Q2 2025 were ARLO ($65.33M), VRNA ($57.50M), DFIN ($51.45M). By sector, the heaviest allocations are Consumer Discretionary 28.4%, Health Care 24.4%. Versus the prior quarter, allocation shifted toward Consumer Discretionary (+1.1pp), Industrials (+1.0pp) and away from Financials (-0.7pp), Health Care (-0.8pp).

Versus the prior quarter, RICE HALL JAMES & ASSOCIATES, LLC opened 9 new positions, trimmed 172 and fully exited 12, a turnover rate of 77.5% of positions. The portfolio's overlap with the prior quarter was 93% of names.

The largest new positions opened in Q2 2025 were SWIM ($3.71M), MTSI ($2.96M), TRS ($2.43M).

Of the 12 positions fully exited versus the prior quarter, the largest were AIN ($3.48M), SWI ($2.59M), TBRG ($2.47M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2025)

  • SWIM LATHAM GROUP INC · $3.71M
  • MTSI MACOM TECH SOLUTIONS HLDGS I · $2.96M
  • TRS TRIMAS CORP · $2.43M
  • PDFS PDF SOLUTIONS INC · $1.96M
  • CGNX COGNEX CORP · $1.72M
  • GO GROCERY OUTLET HLDG CORP · $1.48M
  • COST COSTCO WHOLESALE CORPORATION · $989.94K
  • BTMD BIOTE CORP · $489.05K

Fully Exited (vs previous quarter)

  • AIN ALBANY INTL CORP · prev qtr: $3.48M
  • SWI SOLARWINDS CORP · prev qtr: $2.59M
  • TBRG TRUBRIDGE INC · prev qtr: $2.47M
  • HAIN HAIN CELESTIAL GROUP INC · prev qtr: $1.77M
  • ICFI ICF INTL INC · prev qtr: $1.03M
  • BLBD BLUE BIRD CORP · prev qtr: $950.84K
  • ONT ONTERRIS INC · prev qtr: $940.50K
  • CLNE CLEAN ENERGY FUELS CORP · prev qtr: $488.53K

Insider Transactions (Form 4)

Latest RICE HALL JAMES & ASSOCIATES, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Rice Hall James & Associates, based in San Diego, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 240 positions worth $2.05B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: SAN DIEGO, CA, United States
  • SEC registration: 801-61905 (status: Approved), registered 2003-02-13
  • Regulatory AUM (Form ADV): $1.74B as of 2026-05-06
  • Client mix (by RAUM): pension and profit-sharing plans 62%, individual investors 30%
  • Website: ricehalljames.com

Portfolio Structure

  • 240 positions · $2.05B reported value (Q2 2026)
  • Top 10 holdings = 24.1% of reported value
  • Largest position: LGND (LIGAND PHARMACEUTICALS INC) at 4.2%
  • Average position size: $8.56M

Sector Tilt

  • Health Care 31.6%
  • Consumer Discretionary 25.0%
  • Information Technology 20.2%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q2 2026: 12 new, 94 added, 97 reduced, 15 exited
  • 37 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 24.4%
Technology 16.5%
Financials 4.5%
Other 13.4%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 3.85M $65.33M 3.52%
3.52%
Reduce
2 608.00K $57.50M 3.10%
3.10%
Reduce
3 834.60K $51.45M 2.77%
2.77%
Add
4 333.02K $48.35M 2.60%
2.60%
Reduce
5 259.25K $47.17M 2.54%
2.54%
Reduce
6 719.15K $45.48M 2.45%
2.45%
Reduce
7 539.89K $43.11M 2.32%
2.32%
Reduce
8 900.43K $41.34M 2.23%
2.23%
Reduce
9 337.35K $38.35M 2.06%
2.06%
Add
10 122.19K $36.01M 1.94%
1.94%
Reduce
11 837.71K $35.78M 1.93%
1.93%
Add
12 341.07K $33.80M 1.82%
1.82%
Reduce
13 102.45K $32.16M 1.73%
1.73%
Reduce
14 312.32K $31.66M 1.71%
1.71%
Reduce
15 192.91K $31.34M 1.69%
1.69%
Reduce
16 243.95K $30.81M 1.66%
1.66%
Hold
17 1.04M $28.98M 1.56%
1.56%
Reduce
18 177.39K $28.11M 1.51%
1.51%
Add
19 189.94K $27.90M 1.50%
1.50%
Add
20 160.11K $27.63M 1.49%
1.49%
Hold
21 431.41K $26.46M 1.43%
1.43%
Reduce
22 699.22K $25.88M 1.39%
1.39%
Reduce
23 832.10K $25.19M 1.36%
1.36%
Add
24 127.41K $24.75M 1.33%
1.33%
Reduce
25 261.33K $23.84M 1.28%
1.28%
Reduce
26 142.38K $23.44M 1.26%
1.26%
Add
27 754.13K $22.20M 1.20%
1.20%
Reduce
28 508.62K $19.70M 1.06%
1.06%
Add
29 2.06M $18.46M 0.99%
0.99%
Add
30 213.87K $17.76M 0.96%
0.96%
Add
31 638.23K $17.66M 0.95%
0.95%
Add
32 524.65K $16.54M 0.89%
0.89%
Add
33 103.92K $16.33M 0.88%
0.88%
Add
34 826.80K $16.25M 0.88%
0.88%
Reduce
35 2.76M $15.82M 0.85%
0.85%
Add
36 365.64K $15.76M 0.85%
0.85%
Hold
37 83.31K $15.61M 0.84%
0.84%
Add
38 669.81K $14.45M 0.78%
0.78%
Hold
39 750.66K $14.23M 0.77%
0.77%
Add
40 108.38K $13.62M 0.73%
0.73%
Reduce
41 1.29M $13.47M 0.72%
0.72%
Add
42 281.01K $13.22M 0.71%
0.71%
Reduce
43 184.08K $12.92M 0.70%
0.70%
Reduce
44 533.71K $12.18M 0.66%
0.66%
Add
45 421.88K $12.07M 0.65%
0.65%
Reduce
46 231.99K $11.81M 0.64%
0.64%
Reduce
47 370.63K $11.32M 0.61%
0.61%
Add
48 446.55K $9.82M 0.53%
0.53%
Reduce
49 33.31K $9.71M 0.52%
0.52%
Reduce
50 440.88K $9.69M 0.52%
0.52%
Add

FAQ

What did RICE HALL JAMES & ASSOCIATES, LLC buy in 2025-Q2?

In its 2025-Q2 13F filing, RICE HALL JAMES & ASSOCIATES, LLC reported 247 equity positions worth $1.86B in aggregate; its largest disclosed positions were ARLO ($65.33M), VRNA ($57.50M), DFIN ($51.45M).

How large is RICE HALL JAMES & ASSOCIATES, LLC's portfolio?

RICE HALL JAMES & ASSOCIATES, LLC reported $1.86B of long equity holdings across 247 positions as of 2025-Q2. Top-10 holdings account for 25.5% of reported value.

What is RICE HALL JAMES & ASSOCIATES, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/rice-hall-james-and-associates/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →